Sanjiv Patel
CIK: 0001816210
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Relay Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Oct 7, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct48.2K shares at avg. $18.10$872K - Sep 8, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct48.2K shares at avg. $18.94$913K - Aug 17, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct48.2K shares at avg. $20.33$980K - Jul 7, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct48.2K shares at avg. $19.58$944K - Jun 30, 2026RLAY
Relay Therapeutics, Inc.
Award(A)Direct3.1K shares at avg. $6.95$21K - Jan 13, 2026RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1.5M shares- - Jan 6, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct43.2K shares at avg. $7.82$338K - Dec 31, 2025RLAY
Relay Therapeutics, Inc.
Award(A)Direct994 shares at avg. $2.99$3K - Nov 3, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct62.1K shares at avg. $7.00$435K - Jul 9, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct42.7K shares at avg. $3.57$153K - Jul 9, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct18.6K shares at avg. $3.57$67K - Jun 30, 2025RLAY
Relay Therapeutics, Inc.
Award(A)Direct5K shares at avg. $2.94$15K - Apr 23, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct42.8K shares at avg. $2.97$127K - Apr 23, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct18.7K shares at avg. $2.97$55K - Feb 13, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct75.3K shares at avg. $3.70$279K - Feb 11, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct140.2K shares at avg. $3.85$540K - Feb 11, 2025RLAY
Relay Therapeutics, Inc.
Award(A)Direct332.5K shares- - Jan 23, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Indirect125K shares at avg. $4.78$598K - Jan 22, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Indirect125K shares at avg. $4.80$600K - Jan 21, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Indirect125K shares at avg. $4.52$565K - Jan 10, 2025RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1.1M shares- - Dec 16, 2024RLAY
Relay Therapeutics, Inc.
Sale(S)Indirect100K shares at avg. $5.00$500K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 7, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 48,199 | $18.10 | $872,402 | Direct |
| Sep 8, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 48,199 | $18.94 | $912,889 | Direct |
| Aug 17, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 48,199 | $20.33 | $979,886 | Direct |
| Jul 7, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 48,199 | $19.58 | $943,736 | Direct |
| Jun 30, 2026 | RLAY Relay Therapeutics, Inc. | Award(A) | 3,056 | $6.95 | $21,239 | Direct |
| Jan 13, 2026 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,450,000 | - | - | Direct |
| Jan 6, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 43,168 | $7.82 | $337,574 | Direct |
| Dec 31, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) | 994 | $2.99 | $2,972 | Direct |
| Nov 3, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 62,073 | $7.00 | $434,511 | Direct |
| Jul 9, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 42,740 | $3.57 | $152,582 | Direct |
| Jul 9, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 18,639 | $3.57 | $66,541 | Direct |
| Jun 30, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) | 5,000 | $2.94 | $14,700 | Direct |
| Apr 23, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 42,769 | $2.97 | $127,024 | Direct |
| Apr 23, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 18,653 | $2.97 | $55,399 | Direct |
| Feb 13, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 75,324 | $3.70 | $278,699 | Direct |
| Feb 11, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 140,182 | $3.85 | $539,701 | Direct |
| Feb 11, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) | 332,465 | - | - | Direct |
| Jan 23, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 125,000 | $4.78 | $597,500 | Indirect |
| Jan 22, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 125,000 | $4.80 | $600,000 | Indirect |
| Jan 21, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 125,000 | $4.52 | $565,000 | Indirect |
| Jan 10, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,105,000 | - | - | Direct |
| Dec 16, 2024 | RLAY Relay Therapeutics, Inc. | Sale(S) | 100,000 | $5.00 | $500,000 | Indirect |
1-22 of 22 transactions
About Patel Sanjiv
Patel Sanjiv (SEC CIK 0001816210) files insider reports with the SEC as President and CEO of Relay Therapeutics, Inc. (RLAY).
Signal8 holds 14 ownership filings by Patel Sanjiv, all Form 4s, filed between Dec 18, 2024 and Oct 8, 2026. Those filings report 22 transactions, from Dec 16, 2024 to Oct 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Patel Sanjiv's filings is in CAMBRIDGE, MA.
Recent filings by Patel Sanjiv
- Oct 7, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Sep 8, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Aug 17, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jul 7, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jun 30, 2026: Grant or award of RLAY shares (Form 4, code A).
Other insiders filing for Relay Therapeutics, Inc. (RLAY)
- Rahmer Peter
- Bergstrom Donald A, President, R&D
- Catinazzo Thomas, Chief Financial Officer
- SVF Pauling (Cayman) Ltd, 10% Owner
- Mazumdar Claire, Director
- Dable Habib J, Director